METHODS OF TREATING BRAIN CANCER

Disclosed herein are pharmaceutical compositions for the treatment of cancer. In particular, disclosed herein are methods and uses of the pharmaceutical compositions for treating, preventing and/or managing cancers of the brain and/or central nervous system. The pharmaceutical compositions may compr...

Full description

Saved in:
Bibliographic Details
Main Authors TOOULI, Christian Damian, ZIEGLER, David Simon, RANSON, Richard David
Format Patent
LanguageEnglish
French
Published 09.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed herein are pharmaceutical compositions for the treatment of cancer. In particular, disclosed herein are methods and uses of the pharmaceutical compositions for treating, preventing and/or managing cancers of the brain and/or central nervous system. The pharmaceutical compositions may comprise: (i) 5-FU, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable analogue thereof; (ii) folinic acid, or a pharmaceutically acceptable salt thereof; and (iii) a cyclodextrin or a pharmaceutically acceptable salt thereof. Des compositions pharmaceutiques pour le traitement du cancer sont divulguées. Des procédés et des utilisations des compositions pharmaceutiques pour le traitement, la prévention et/ou la gestion de cancers du cerveau et/ou du système nerveux central sont, en particulier, divulgués. Les compositions pharmaceutiques peuvent comprendre : (i) 5-FU, un sel pharmaceutiquement acceptable de celui-ci ou un analogue pharmaceutiquement acceptable de celui-ci ; (ii) de l'acide folinique ou un sel pharmaceutiquement acceptable de celui-ci ; et (iii) une cyclodextrine ou un sel pharmaceutiquement acceptable de celle-ci.
Bibliography:Application Number: WO2021AU50848